UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

Paliperidone extended-release for schizophrenia: Effects on symptoms and functioning in acutely ill patients with negative symptoms

Schizophrenia research, 2009-08, Vol.113 (1), p.56-64

2009

Volltextzugriff (PDF)

Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases

International journal of clinical practice (Esher), 2014-12, Vol.68 (12), p.1514-1522

2014

Volltextzugriff (PDF)

301 – Patterns of response with paliperidone ER and placebo in patients with schizophrenia

Schizophrenia research, 2008-02, Vol.98, p.157-157

2008

Volltextzugriff (PDF)

20 – Placebo response in controlled clinical trials of patients with schizophrenia: A decade of differences

Schizophrenia research, 2008-02, Vol.98, p.41-41

2008

Volltextzugriff (PDF)

32 – Remission in schizophrenia and patient-relevant outcomes: Findings from three studies

Schizophrenia research, 2008-02, Vol.98, p.46-47

2008

Volltextzugriff (PDF)

Frequently relapsing bipolar disorder: Evidence for an effective treatment

Schizophrenia research, 2008-02, Vol.98, p.5-5

2008

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently

Bipolar disorders, 2009-12, Vol.11 (8), p.827-839

2009

Volltextzugriff (PDF)

Impact of self-reported juvenile abuse on treatment outcome in patients with major depressive disorder

Journal of affective disorders, 2013-10, Vol.151 (1), p.384-391

2013

Volltextzugriff (PDF)

A cDNA from Drosophila melanogaster encodes a lamin C-like intermediate filament protein

Journal of cell science, 1993-04, Vol.104 (4), p.1263-1272

1993

Volltextzugriff (PDF)

Mutational analysis of the Drosophila tolloid gene, a human BMP-1 homolog

Development (Cambridge), 1994-04, Vol.120 (4), p.861-870

1994

Volltextzugriff (PDF)

tolkin gene is a tolloid/BMP-1 homologue that is essential for Drosophila development

Genetics (Austin), 1995-09, Vol.141 (1), p.271-281

1995

Volltextzugriff (PDF)

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization

Schizophrenia research, 2006-07, Vol.85 (1), p.254-265

2006

Volltextzugriff (PDF)

Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection

Schizophrenia research, 2005-09, Vol.77 (2), p.215-227

2005

Volltextzugriff (PDF)

Paliperidone Extended-Release in Schizoaffective Disorder: A Randomized, Controlled Study Comparing a Flexible Dose With Placebo in Patients Treated With and Without Antidepressants and/or Mood Stabilizers

Journal of clinical psychopharmacology, 2010-10, Vol.30 (5), p.487-495

2010

Volltextzugriff (PDF)

Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam

The journal of clinical psychiatry, 2004-03, Vol.65 (3), p.386

2004

Volltextzugriff (PDF)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics

Neuropsychiatric disease and treatment, 2013-01, Vol.9 (default), p.341-350

2013

Volltextzugriff (PDF)

Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone

International clinical psychopharmacology, 2008-07, Vol.23 (4), p.209

2008

Volltextzugriff (PDF)

Effect of long-acting injectable risperidone on clinical outcomes in recently diagnosed stable schizophrenia patients

The international journal of neuropsychopharmacology, 2008-07, Vol.11, p.157

2008

Volltextzugriff (PDF)

Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia

International clinical psychopharmacology, 2010-03, Vol.25 (2), p.75

2010

Volltextzugriff (PDF)

Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone

International clinical psychopharmacology, 2006-07, Vol.21 (4), p.233

2006

Volltextzugriff (PDF)

Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: Analysis of a multicenter, rater-blinded, open-label study

Clinical therapeutics, 2005-12, Vol.27 (12), p.1930-1941

2005

Volltextzugriff (PDF)

Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone

European psychiatry, 2004-06, Vol.19 (4), p.219-225

2004

Volltextzugriff (PDF)

Onset and Persistence of Antipsychotic Response in Patients With Schizophrenia

Journal of clinical psychopharmacology, 2009-12, Vol.29 (6), p.542-547

2009

Volltextzugriff (PDF)

Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): Cross-scale comparison in assessing tardive dyskinesia

Schizophrenia research, 2005-09, Vol.77 (2), p.119-128

2005

Volltextzugriff (PDF)

Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial

The international journal of neuropsychopharmacology, 2005-09, Vol.8 (3), p.427-438

2005

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(106)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Humans
(40)
Life Sciences & Biomedicine
(40)
Psychiatry
(33)
Biological And Medical Sciences
(31)
Female
(29)
Male
(28)
Adult
(26)
Medical Sciences
(25)
Schizophrenia
(23)
Schizophrenia - Drug Therapy
(23)
Pharmacology. Drug Treatments
(22)
Neuropharmacology
(21)
Psychology. Psychoanalysis. Psychiatry
(20)
Psychopharmacology
(19)
Antipsychotic Agents - Therapeutic Use
(18)
Middle Aged
(18)
Risperidone - Therapeutic Use
(18)
Psycholeptics: Tranquillizer, Neuroleptic
(16)
Antipsychotic Agents - Administration & Dosage
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Paliperidone extended-release for schizophrenia: Effects on symptoms and functioning in acutely ill patients with negative symptoms

Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases

301 – Patterns of response with paliperidone ER and placebo in patients with schizophrenia

20 – Placebo response in controlled clinical trials of patients with schizophrenia: A decade of differences

32 – Remission in schizophrenia and patient-relevant outcomes: Findings from three studies

Frequently relapsing bipolar disorder: Evidence for an effective treatment

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently

Impact of self-reported juvenile abuse on treatment outcome in patients with major depressive disorder

A cDNA from Drosophila melanogaster encodes a lamin C-like intermediate filament protein

Mutational analysis of the Drosophila tolloid gene, a human BMP-1 homolog

tolkin gene is a tolloid/BMP-1 homologue that is essential for Drosophila development

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization

Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection

Paliperidone Extended-Release in Schizoaffective Disorder: A Randomized, Controlled Study Comparing a Flexible Dose With Placebo in Patients Treated With and Without Antidepressants and/or Mood Stabilizers

Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics

Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone

Effect of long-acting injectable risperidone on clinical outcomes in recently diagnosed stable schizophrenia patients

Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia

Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone

Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: Analysis of a multicenter, rater-blinded, open-label study

Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone

Onset and Persistence of Antipsychotic Response in Patients With Schizophrenia

Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): Cross-scale comparison in assessing tardive dyskinesia

Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial

Suchergebnisse filtern